Interventional Cardiology Devices Market Size, Share Revenue to Grow At 9.6% during forecast period 2021 to 2027

SHARE THIS ARTICLE

Latest Study on “Interventional Cardiology Devices Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2027”.

The global Interventional Cardiology Devices market size is expected to be worth around US$ 23.5 billion by 2027, according to a new report by nova one advisor.

The global Interventional Cardiology Devices market size was valued at US$ 12.9 billion in 2020 and is anticipated to grow at a CAGR of 9.6% during forecast period 2021 to 2027.

Overview of Interventional Cardiology Devices Market Study

Interventional Cardiology Devices market study conducted by Nova One Advisor is intended at helping stakeholders get a comprehensive overview of potential challenges and undiscovered opportunities. The report offers exclusive insights to help companies and their customers to make informed decision to sustain growth through the assessment period.

Get your Customized Research Report@ https://www.novaoneadvisor.com/report/customization/4400

Growth Factors:

Growth in this market is majorly driven by the rapid growth in the geriatric population and the associated increase in the prevalence of coronary artery diseases, the approval of new and advanced products, and the rising incidence of diabetes. However, the availability of alternative treatments and product failures and recalls are the major factors that are expected to restrain the growth of this market during the forecast period.

Global Interventional cardiology Devices Market Dynamics

Driver: growing prevalence of coronary artery diseases

According to the Centers for Disease Control and Prevention (CDC), coronary artery disease (CAD) is the most common type of heart disease in the US, killing 365,914 people in 2017. The CDC also estimates that nearly 18.2 million people above the age of 20 are currently suffering from CAD in the US. According to the British Heart Foundation, as of June 2020, there were 2.3 million people in the UK living with CAD. Each year, 170,000 people die from heart and circulatory diseases in the UK. Such a massive patient population and the high mortality rate is expected to increase the demand for interventional cardiology devices in the coming years.

Risk factors, such as diabetes and hypertension, also fuel the demand for interventional cardiology devices. People with diabetes are more likely to have other conditions that raise the risk of coronary heart disease. Over time, high blood sugar can damage the blood vessels that control the heart. According to the International Diabetes Federation (IDF), globally, the number of people suffering from diabetes is expected to reach 700 million by 2045 from 463 million in 2019. In the US alone, 1.5 million Americans are diagnosed with diabetes each year [Source: American Diabetes Association (ADA)]. Growth in diabetes prevalence can largely be attributed to the growth in the geriatric population; it is estimated that 25% of all geriatric individuals (aged 60 years and above) suffer from diabetes in the US (Source: ADA)

Buy Complete Assessment of Interventional Cardiology Devices market Now@ https://www.novaoneadvisor.com/report/checkout/4400

COVID-19 Impact on Interventional Cardiology Devices Sales

Businesses today are operating in a dynamic environment. Earlier focus primarily concentrated on keeping pace with changing consumer preferences. COVID-19 outbreak was unprecedented and exposed vulnerabilities of various industries. Pandemic-induces obstacles also were registered in the Interventional Cardiology Devices market.

Sales plummeted as COVID-19 gradually tightened its noose worldwide. Supply-chain disruptions caused massive losses, while demand took nose-dive as consumers remained indoors with affected countries implementing either partial or complete lockdown.

Gradual recovery however is on the cards with the roll out of vaccinations. Nonetheless, consecutive waves of the virus compelled businesses to stay prepared for the worst. As government and healthcare organizations successfully implement steps to contain the spread of COVID-19, industries have begun operations, albeit at a slow and more cautious pace.

Against this backdrop, Nova one advisor’s study predicts gradual recovery for the Interventional Cardiology Devices market 2021 onwards. This trend will however continue through the course of the report’s assessment period

Key Players:

This report provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the Interventional Cardiology Devices market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.

Some of the prominent players in the Interventional Cardiology Devices market include:

Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), Edward Lifescinces Corporation (US) Cardinal Health (US), iVascular (Spain), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KG (Germany)

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

By Product

  • Angioplasty Balloons
    • Old/Normal Balloons
    • Drug-eluting Balloons
    • Cutting and Scoring Balloons
  • Angioplasty Stents
    • Drug-eluting Stents
    • Bare-metal Stents
    • Bioabsorbable Stents
  • Structural Heart Devics
    • Aortic Valve Therapy Devices
    • Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)
  • Catheters
    • Angiography Catheters
    • Guiding Catheters
    • IVUS/OCT Catheters
  • Plaque Modification Devices
    • Atherectomy Devices
    • Thrombectomy Devices
  • Hemodynamic Flow Alteration Devices
    • Embolic Protection Devices
    • Chronic Total Occlusion Devices
  • Other Devices
    • Guidewires
    • Vascular Closure Devices
    • Introducer Sheaths
    • Hemostasis Valves
    • Balloon Inflation Devices

Browse Complete Table of Content@ https://www.novaoneadvisor.com/toc/interventional-cardiology-devices-market

Why Buy this Report?

The purpose of Nova one advisor’s Interventional Cardiology Devices market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

Download This Full Research Report, Click Here@ https://www.novaoneadvisor.com/report/checkout/4400

About Us

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@novaoneadvisor.com

Web: https://www.novaoneadvisor.com/

James Root

James Root have over 6+ years of experience working in business development, and customer retention. I’ve gained my experience through serving higher education, healthcare, automotive, aerospace, manufacturing, local government and hospitality businesses with technical solutions.

View all posts by James Root →

Leave a Reply

Your email address will not be published. Required fields are marked *